{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:13:30Z","timestamp":1792512810980,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The Impella 5.5\u00ae was approved by the FDA for use for mechanical circulatory support up to 14\u00a0days in late 2019 at limited centers in the United States. Our single center\u2019s experience with Impella 5.5\u00ae can expand the overall understanding for achieving successful patient outcomes as well as provide support for the expansion of its FDA-approved use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is an IRB-approved single-center retrospective cohort analysis of hospitalized adult patient characteristics and outcomes in cases where the Impella 5.5\u00ae was utilized for mechanical circulatory support.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 26 implanted Impella 5.5\u00ae devices were identified in 24 hospitalized patients at our institution from January 2020 to January 2021. The overall survival rate during index hospitalization was 75%. Eleven Impella 5.5\u00ae devices were identified in 10 patients with an average device implantation greater than 14\u00a0days. Average device implantation for this subgroup was 27\u00a0days with a range of 15\u201380\u00a0days. Survival rate for Impella 5.5\u00ae use greater than 14\u00a0days was 67%. In the entire cohort and subgroup of device implantation\u2009&gt;\u200914\u00a0days, evidence of end organ damage improved with Impella 5.5\u00ae use. Complications in our cohort and subgroup of device implantation\u2009&gt;\u200914\u00a0days were similar to previously reported complication incidence of axillary inserted LVAD devices.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our institution\u2019s experience with the Impella 5.5\u00ae has been strongly positive with favorable outcomes and helps to establish the Impella 5.5\u00ae as a viable option for mechanical circulatory support beyond 14\u00a0days.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01871-1","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T13:04:14Z","timestamp":1653311054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Single center first year experience and outcomes with Impella 5.5 left ventricular assist device"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2050-5124","authenticated-orcid":false,"given":"Joanna R.","family":"Rock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyaal","family":"Moin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dulnuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"4","key":"1871_CR1","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.healun.2020.01.970","volume":"39","author":"L Castro","year":"2020","unstructured":"Castro L, Krause L, Reichenspurner H, Bernhardt A. Worldwide gender differences during mechanical circulatory support: an analysis of the international society for heart and lung transplantation mechanically assisted circulatory support registry data. J Heart Lung Transpl. 2020;39(4):S107\u20138. https:\/\/doi.org\/10.1016\/j.healun.2020.01.970.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"1871_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.11909\/j.issn.1671-5411.2016.05.015","volume":"13","author":"SY Chair","year":"2016","unstructured":"Chair SY, Yu DS, Ng MT, et al. Evolvement of left ventricular assist device: the implications on heart failure management. J Geriatr Cardiol. 2016;13(5):425\u201330. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2016.05.015.","journal-title":"J Geriatr Cardiol"},{"issue":"4","key":"1871_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/IMI.0000000000000535","volume":"13","author":"G Batsides","year":"2018","unstructured":"Batsides G, Massaro J, Cheung A, Soltesz E, Ramzy D, Anderson MB. Outcomes of Impella 5.0 in cardiogenic shock: a systematic review and meta-analysis. Innovations. 2018;13(4):254\u201360. https:\/\/doi.org\/10.1097\/IMI.0000000000000535.","journal-title":"Innovations"},{"issue":"1","key":"1871_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.athoracsur.2013.07.053","volume":"97","author":"A Lemaire","year":"2014","unstructured":"Lemaire A, Anderson MB, Lee LY, et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock. Ann Thorac Surg. 2014;97(1):133\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2013.07.053.","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"1871_CR5","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.jacc.2015.02.043","volume":"65","author":"CS Rihal","year":"2015","unstructured":"Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care. J Am Coll Cardiol. 2015;65(19):2140\u20131. https:\/\/doi.org\/10.1016\/j.jacc.2015.02.043.","journal-title":"J Am Coll Cardiol"},{"key":"1871_CR6","unstructured":"Langford T, Goldberg-Ward I. Abiomed Receives FDA PMA Approval for Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump. ABIOMED, Inc. http:\/\/investors.abiomed.com\/news-releases\/news-release-details\/abiomed-receives-fda-pma-approval-impella-55-smartassist. Published September 25, 2019. Accessed 12 Nov 2020."},{"key":"1871_CR7","unstructured":"Karr S. First 1,000 Patients Treated with Impella 5.5 with SmartAssist, a Heart Pump Designed for Surgeons. https:\/\/www.businesswire.com\/news\/home\/20201105005280\/en\/. Published November 5, 2020. Accessed 12 Nov 2020."},{"issue":"7","key":"1871_CR8","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/MAT.0000000000001194","volume":"66","author":"D Ramzy","year":"2020","unstructured":"Ramzy D, Soltesz E, Anderson M. New surgical circulatory support system outcomes. ASAIO J (1992). 2020;66(7):746\u201352. https:\/\/doi.org\/10.1097\/MAT.0000000000001194.","journal-title":"ASAIO J (1992)"},{"issue":"4","key":"1871_CR9","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.healun.2020.01.950","volume":"39","author":"P Bernhardt","year":"2020","unstructured":"Bernhardt P. First in men multicenter experience with the Impella 5.5. J Heart Lung Transpl. 2020;39(4):S99\u2013S99. https:\/\/doi.org\/10.1016\/j.healun.2020.01.950.","journal-title":"J Heart Lung Transpl"},{"issue":"Suppl_1 Suppl 1","key":"1871_CR10","doi-asserted-by":"publisher","first-page":"A15478","DOI":"10.1161\/circ.140.suppl_1.15478","volume":"140","author":"R Desai","year":"2019","unstructured":"Desai R, Patel U, Singh S, et al. Abstract 15478: in-hospital and 30-day outcomes following acute mechanical circulatory support with Impella 5.0\u00ae\/LD\u00ae device: an updated systematic review and meta-analysis. Circulation. 2019;140(Suppl_1 Suppl 1):A15478\u2013A15478. https:\/\/doi.org\/10.1161\/circ.140.suppl_1.15478.","journal-title":"Circulation"},{"issue":"4","key":"1871_CR11","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.1016\/j.healun.2020.01.189","volume":"39","author":"H Patel","year":"2020","unstructured":"Patel H, Suarez E, Bruckner B, Ngo U, Bhimaraj A. Axillary Impella 5.0 outcomes: a single center review. J Heart Lung Transpl. 2020;39(4):S417\u2013S417. https:\/\/doi.org\/10.1016\/j.healun.2020.01.189.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"1871_CR12","doi-asserted-by":"publisher","first-page":"S342","DOI":"10.1016\/j.healun.2019.01.867","volume":"38","author":"H Bernhardt","year":"2019","unstructured":"Bernhardt H. First-in-man implantations of a newly developed transaortic axial flow ventricular assist device (Impella 5.5). J Heart Lung Transpl. 2019;38(4):S342\u2013S342. https:\/\/doi.org\/10.1016\/j.healun.2019.01.867.","journal-title":"J Heart Lung Transpl"},{"issue":"5","key":"1871_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ejhf.260","volume":"17","author":"V Harjola","year":"2015","unstructured":"Harjola V, Lassus J, Sionis A, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501\u20139. https:\/\/doi.org\/10.1002\/ejhf.260.","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"1871_CR14","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/j.1478-3231.2011.02655.x","volume":"32","author":"J Henrion","year":"2012","unstructured":"Henrion J. Hypoxic hepatitis. Liver Int. 2012;32(7):1039\u201352. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02655.x.","journal-title":"Liver Int"},{"issue":"1","key":"1871_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/ki.2014.328","volume":"87","author":"M Thomas","year":"2015","unstructured":"Thomas M, Blaine C, Dawnay A, Devonald M, Ftouh S, Laing C, Latchem S, Lewington A, Milford D, Ostermann M. The definition of acute kidney injury and its use in practice. Kidney Int. 2015;87(1):62\u201373. https:\/\/doi.org\/10.1038\/ki.2014.328.","journal-title":"Kidney Int"},{"key":"1871_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/HMER.S74612","volume":"8","author":"O Mitchell","year":"2016","unstructured":"Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016;8:39\u201350. https:\/\/doi.org\/10.2147\/HMER.S74612.","journal-title":"Hepat Med"},{"key":"1871_CR17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.12688\/f1000research.25518.1","volume":"9","author":"NK Kapur","year":"2020","unstructured":"Kapur NK, Whitehead EH, Thayer KL, Pahuja M. The science of safety: complications associated with the use of mechanical circulatory support in cardiogenic shock and best practices to maximize safety [version 1; peer review: 2 approved]. F1000 Research. 2020;9:794. https:\/\/doi.org\/10.12688\/f1000research.25518.1.","journal-title":"F1000 Research."},{"issue":"2","key":"1871_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jocs.13978","volume":"34","author":"L Bertoglio","year":"2019","unstructured":"Bertoglio L, Katsarou M, Scandroglio M, Bertoldi L, Chiesa R, Pappalardo F. Surgical transaxillary placement of the Impella 5.0 ventricular assist device. J Cardiac Surg. 2019;34(2):92\u20138. https:\/\/doi.org\/10.1111\/jocs.13978.","journal-title":"J Cardiac Surg"},{"issue":"5","key":"1871_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.resuscitation.2012.10.001","volume":"84","author":"S Manzo-Silberman","year":"2012","unstructured":"Manzo-Silberman S, Fichet J, Mathonnet A, et al. Percutaneous left ventricular assistance in post cardiac arrest shock: comparison of intra aortic blood pump and IMPELLA Recover LP2.5. Resuscitation. 2012;84(5):609\u201315. https:\/\/doi.org\/10.1016\/j.resuscitation.2012.10.001.","journal-title":"Resuscitation"},{"key":"1871_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.01.028","author":"A Moustafa","year":"2021","unstructured":"Moustafa A, Khan MS, Saad M, Siddiqui S, Eltahawy E. Impella support versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: a meta-analysis. Cardiovasc Revasc Med. 2021. https:\/\/doi.org\/10.1016\/j.carrev.2021.01.028.","journal-title":"Cardiovasc Revasc Med"},{"issue":"1","key":"1871_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/joic.12080","volume":"27","author":"WW O\u2019Neill","year":"2014","unstructured":"O\u2019Neill WW, Schreiber T, Wohns DHW, et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella registry. J Int Cardiol. 2014;27(1):1\u201311. https:\/\/doi.org\/10.1111\/joic.12080.","journal-title":"J Int Cardiol"},{"issue":"2","key":"1871_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/CIRCOUTCOMES.115.002359","volume":"9","author":"RJ Goldberg","year":"2016","unstructured":"Goldberg RJ, Makam RCP, Yarzebski J, McManus DD, Lessard D, Gore JM. Decade long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction: goldberg et al: cardiogenic shock and AMI. Circ Cardiovasc Qual Outcomes. 2016;9(2):117\u201325. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.115.002359.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"1871_CR23","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.healun.2015.01.056","volume":"34","author":"A Bernhardt","year":"2015","unstructured":"Bernhardt A, Sill B, Wagner F, et al. Gender differences in mechanical circulatory support: insights from a european registry. J Heart Lung Transpl. 2015;34(4):S25\u2013S25. https:\/\/doi.org\/10.1016\/j.healun.2015.01.056.","journal-title":"J Heart Lung Transpl"},{"issue":"4","key":"1871_CR24","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/MAT.0b013e318251cdf9","volume":"58","author":"E Potapov","year":"2012","unstructured":"Potapov E, Schweiger M, Lehmkuhl E, et al. Gender differences during mechanical circulatory support. ASAIO J (1992). 2012;58(4):320\u20135. https:\/\/doi.org\/10.1097\/MAT.0b013e318251cdf9.","journal-title":"ASAIO J (1992)"},{"issue":"5","key":"1871_CR25","doi-asserted-by":"publisher","first-page":"e64457","DOI":"10.1371\/journal.pone.0064457","volume":"8","author":"EO Talbott","year":"2013","unstructured":"Talbott EO, Rager JR, Brink LL, et al. Trends in acute myocardial infarction hospitalization rates for US States in the CDC tracking network. PLoS ONE. 2013;8(5):e64457\u2013e64457. https:\/\/doi.org\/10.1371\/journal.pone.0064457.","journal-title":"PLoS ONE"},{"issue":"5","key":"1871_CR26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.acvd.2014.04.005","volume":"107","author":"G Leurent","year":"2014","unstructured":"Leurent G, Garlant\u00e9zec R, Auffret V, et al. Gender differences in presentation, management and inhospital outcome in patients with ST-segment elevation myocardial infarction: data from 5000 patients included in the ORBI prospective French regional registry. Arch Cardiovasc Dis. 2014;107(5):291\u20138. https:\/\/doi.org\/10.1016\/j.acvd.2014.04.005.","journal-title":"Arch Cardiovasc Dis"},{"issue":"19","key":"1871_CR27","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.168.19.2138","volume":"168","author":"H Bahrami","year":"2008","unstructured":"Bahrami H, Kronmal R, Bluemke DA, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med (1960). 2008;168(19):2138\u201345. https:\/\/doi.org\/10.1001\/archinte.168.19.2138.","journal-title":"Arch Intern Med (1960)"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01871-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01871-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01871-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T13:08:47Z","timestamp":1653311327000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01871-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1871"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01871-1","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is an institutional IRB-approved single-center retrospective cohort analysis of hospitalized adult patient characteristics and outcomes in cases where an axillary minimally invasive axial LVAD, the Impella 5.5\u00ae with SmartAssist\u00ae (Abiomed, Danvers, MA), was utilized for mechanical circulatory support over a period of one year. Consent was waived by the IRB board at our institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the data presented in this manuscript has been de-identified. Consent for participation was waived by the IRB board at our institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}